AMSBIO and Chondrex Cooperate on Reagents Provision

AMSBIO (UK) has announced a pan European partnership with US company Chondrex Inc. to market high quality arthritis and inflammation reagents to academics and pharmaceutical companies that do research in these fields.

The range includes a suite of high quality reagents such as highly purified cartilage collagen and collagen monoclonal antibodies to provide scientists with the necessary tools to study the pathogenesis as well as to develop and screen potential therapeutics for Rheumatoid Arthritis (RA). In addition, AMSBIO has also improved its capability to provide reagents and various assay kits for the investigation of other important inflammatory diseases such as nephritis and allergic asthma.

Multi species Collagen reactive antibodies are available that can be used in western blotting, immunostaining and for inducing Collagen Antibody-Induced Arthritis (CAIA).